Cardiovascular risk in type 2 diabetes patients-Reference-Cited by-同舟云学术

Cardiovascular risk in type 2 diabetes patients

Published:2018-08-20 Issue:4 Volume:17 Page:81-94
ISSN:2619-0125
Container-title:Cardiovascular Therapy and Prevention
language:
Short-container-title:Cardiovasc Ther Prev

Author:

Ostroumova O. D.¹^ORCID,Goloborodova I. V.²^ORCID,Fomina V. М.²^ORCID

Affiliation:

1. A. I. Evdokimov Moscow State University of Medicine and Dentistry (MSUMD); I.M. Sechenov First Moscow State Medical University of the Ministry of Health

2. A.I. Evdokimov Moscow State University of Medicine and Dentistry (MSUMD)

Abstract

Cardiovascular diseases remain leading cause of high mortality in diabetes patients. The article is focused on the influence of diabetes on cardiovascular risks. The prevalence presented, as the significance of the main and additional risk factors of cardiovascular diseases in the development of macrovascular complications in diabetes. In the context of influence on cardiovascular risks, modern glucose lowering drugs are considered, the safety and efficacy properties. Advantages of dapagliflozin underscored, the novel oral drug of new generation, with safe and prominent antidiabetic effect and ability to correct the main factors of cardiovascular risk (obesity, hypertension).

Publisher

Silicea - Poligraf, LLC

Subject

Cardiology and Cardiovascular Medicine

Reference84 articles.

1. IDF Diabetes Atlas, 8th edition. Brussels: International Diabetes Federation; 2017. Available from: https://www.idf.org/e-library/epidemiologyresearch/diabetesatlas/134-idf-diabetes-atlas-8th-edition.html.

2. Dedov II, Shestakova MV, Vikulova OK. Epidemiology of diabetes in the Russian Federation: clinical and statistical analysis according to the Federal register of diabetes. Diabetes Mellitus. 2017;1(20):13-41. (In Russ.)

3. Nwaneri C, Cooper H, Bowen-Jones D. Mortality in type 2 diabetes mellitus: magnitude of the evidence from a systematic review and meta-analysis. The British Journal of Diabetes & Vascular Disease. 2013;4(13):192-207. doi:10.1177/1474651413495703.

4. Sarwar N, Gao P, Seshasai SR, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375:2215-22. doi:10.1016/S0140-6736(10)60484-9.

5. Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. British Medical Journal. 2006;332:73-8. doi:10.1136/bmj.38678.389583.7C.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Arterial hypertension as a consequence of endothelial glycocalyx dysfunction: a modern view of the problem of cardiovascular diseases;Cardiovascular Therapy and Prevention;2022-09-12

2. Indicators of lipid peroxidation and the activity of antioxidant system enzymes as predictors of the development of metabolic disorders in primary obesity;Kazan medical journal;2021-10-13

3. Gender characteristics of lipid profile parameters and markers of vascular inflammation in patients with stable angina pectoris in groups with presence and absence of type 2 diabetes;Russian Clinical Laboratory Diagnostics;2021-06-07